# Alibaba Group Holding Ltd: financial statements, quarterly

BABA · NYSE · CIK 1577552 · [Industrials](/sectors/industrials.md)

Pages: [Overview](/companies/baba.md) · [Financials](/companies/baba/financials.md) · [Filings](/companies/baba/filings.md) · [Insiders](/companies/baba/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/baba/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2015 (2015-03-31) | FY2016 (2016-03-31) | FY2017 (2017-03-31) | FY2018 (2018-03-31) | FY2019 (2019-03-31) | FY2020 (2020-03-31) | FY2021 (2021-03-31) | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [16.8](/filings/0001047469-16-013400.md) | [15.5](/filings/0001047469-17-004019.md) | [22.9](/filings/0001047469-18-005257.md) | [31.8](/filings/0001047469-18-005257.md) | [28.3](/filings/0001047469-19-003492.md) | [46.7](/filings/0001104659-20-082409.md) | [49.0](/filings/0001104659-21-096092.md) | [30.0](/filings/0001104659-22-082622.md) | [28.1](/filings/0000950170-23-033752.md) | [34.4](/filings/0000950170-24-063767.md) | [20.0](/filings/0000950170-25-090161.md) | [19.1](/filings/0001193125-26-231755.md) |
| Current assets | $bn | [22.9](/filings/0001047469-15-005768.md) | [20.8](/filings/0001047469-16-013400.md) | [26.5](/filings/0001047469-17-004019.md) | [40.9](/filings/0001047469-18-005257.md) | [40.3](/filings/0001047469-19-003492.md) | [65.4](/filings/0001104659-20-082409.md) | [98.2](/filings/0001104659-21-096092.md) | [101](/filings/0001104659-22-082622.md) | [102](/filings/0000950170-23-033752.md) | [104](/filings/0000950170-24-063767.md) | [92.9](/filings/0000950170-25-090161.md) | [88.5](/filings/0001193125-26-231755.md) |
| Total assets | $bn | [41.2](/filings/0001047469-15-005768.md) | [56.5](/filings/0001047469-16-013400.md) | [73.6](/filings/0001047469-17-004019.md) | [114](/filings/0001047469-18-005257.md) | [144](/filings/0001047469-19-003492.md) | [185](/filings/0001104659-20-082409.md) | [258](/filings/0001104659-21-096092.md) | [267](/filings/0001104659-22-082622.md) | [255](/filings/0000950170-23-033752.md) | [244](/filings/0000950170-24-063767.md) | [249](/filings/0000950170-25-090161.md) | [277](/filings/0001193125-26-231755.md) |
| Current liabilities | $bn | [6.4](/filings/0001047469-15-005768.md) | [8.1](/filings/0001047469-16-013400.md) | [13.6](/filings/0001047469-17-004019.md) | [21.7](/filings/0001047469-18-005257.md) | [30.9](/filings/0001047469-19-003492.md) | [34.2](/filings/0001104659-20-082409.md) | [57.6](/filings/0001104659-21-096092.md) | [60.5](/filings/0001104659-22-082622.md) | [56.1](/filings/0000950170-23-033752.md) | [58.4](/filings/0000950170-24-063767.md) | [60.0](/filings/0000950170-25-090161.md) | [69.1](/filings/0001193125-26-231755.md) |
| Total liabilities | $bn | [15.7](/filings/0001047469-15-005768.md) | [17.8](/filings/0001047469-16-013400.md) | [26.5](/filings/0001047469-17-004019.md) | [44.3](/filings/0001047469-18-005257.md) | [52.1](/filings/0001047469-19-003492.md) | [61.2](/filings/0001104659-20-082409.md) | [92.6](/filings/0001104659-21-096092.md) | [96.8](/filings/0001104659-22-082622.md) | [91.8](/filings/0000950170-23-033752.md) | [90.3](/filings/0000950170-24-063767.md) | [98.4](/filings/0000950170-25-090161.md) | [114](/filings/0001193125-26-231755.md) |
| Current portion of debt | $bn | [0.3](/filings/0001047469-15-005768.md) | [0.7](/filings/0001047469-16-013400.md) | [0.9](/filings/0001047469-17-004019.md) | [1.0](/filings/0001047469-18-005257.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | [1.1](/filings/0001047469-19-003492.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [23.5](/filings/0001047469-15-005768.md) | [33.7](/filings/0001047469-16-013400.md) | [40.5](/filings/0001047469-17-004019.md) | [58.3](/filings/0001047469-18-005257.md) | [73.3](/filings/0001047469-19-003492.md) | [107](/filings/0001104659-20-082409.md) | [143](/filings/0001104659-21-096092.md) | [150](/filings/0001104659-22-082622.md) | [144](/filings/0000950170-23-033752.md) | [137](/filings/0000950170-24-063767.md) | [139](/filings/0000950170-25-090161.md) | [154](/filings/0001193125-26-231755.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 1,858,037,427 at 2026-03-31, from the cover of the [20-F filed 2026-05-20](/filings/0001193125-26-231755.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.